Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mostafa Nakach is active.

Publication


Featured researches published by Mostafa Nakach.


International Journal of Pharmaceutics | 2014

Engineering of nano-crystalline drug suspensions: Employing a physico-chemistry based stabilizer selection methodology or approach

Mostafa Nakach; Jean-Rene Authelin; Tharwat Tadros; Laurence Galet; Alain Chamayou

This paper describes a systematic approach to select optimum stabilizer for the preparation of nano-crystalline suspensions of an active pharmaceutical ingredient (API). The stabilizer can be either a dispersant or a combination of dispersant and wetting agent. The proposed screening method is a quick and efficient way to investigate a large number of stabilizers based on the principles of physical-chemistry and employs a stepwise approach. The methodology has been divided in two main parts; the first part being focused on the qualitative screening with the objective of selecting the best candidate(s) for further investigation, the second part has been focused on quantitative screening with the objective to optimize the ratio and amount of wetting and dispersing agents, based on wettability, surface charges measurement, adsorption evaluation, process-ability evaluation and storage stability. The results showed clearly that SDS/PVP 40/60% (w/w) (sodium dodecyl sulfate/poly(vinyl pyrrolidone)) at a total concentration of 1.2% was the optimum stabilizer composition, at which the resulting nanosuspensions were stable for more than 50 days at room temperature.


International Journal of Pharmaceutics | 2016

Assessment of formulation robustness for nano-crystalline suspensions using failure mode analysis or derisking approach

Mostafa Nakach; Jean-Rene Authelin; Cecile Voignier; Tharwat Tadros; Laurence Galet; Alain Chamayou

The small particle size of nano-crystalline suspensions can be responsible for their physical instability during drug product preparation (downstream processing), storage and administration. For that purpose, the commercial formulation needs to be sufficiently robust to various triggering conditions, such as ionic strength, shear rate, wetting/dispersing agent desorption by dilution, temperature and pH variation. In our previous work we described a systematic approach to select the suitable wetting/dispersant agent for the stabilization of nano-crystalline suspension. In this paper, we described the assessment of the formulation robustness (stabilized using a mixture of sodium dodecyl sulfate (SDS) and polyvinylpyrrolidone (PVP) and) by measuring the rate of perikinetic (diffusion-controlled) and orthokinetic (shear-induced) aggregation as a function of ionic strength, temperature, pH and dilution. The results showed that, using the SDS/PVP system, the critical coagulation concentration is about five times higher than that observed in the literature for suspension colloidaly stable at high concentration. The nano-suspension was also found to be very stable at ambient temperature and at different pH conditions. Desorption test confirmed the high affinity between API and wetting/dispersing agent. However, the suspension undergoes aggregation at high temperature due to the desorption of the wetting/dispersing agent and disaggregation of SDS micelles. Furthermore, aggregation occurs at very high shear rate (orhokinetic aggregation) by overcoming the energy barrier responsible for colloidal stability of the system.


International Journal of Pharmaceutics | 2018

Comparison of high pressure homogenization and stirred bead milling for the production of nano-crystalline suspensions

Mostafa Nakach; Jean-Rene Authelin; Marc-Antoine Perrin; Harivardhan Reddy Lakkireddy

Graphical abstract Figure. No caption available. ABSTRACT Currently, the two technologies primarily used for the manufacturing of nano‐crystalline suspensions using top down process (i.e. wet milling) are high pressure homogenization (HPH) and stirred bead milling (SBM). These two technologies are based upon different mechanisms, i.e., cavitation forces for HPH and shear forces for stirred bead milling. In this article, the HPH and SBM technologies are compared in terms of the impact of the suspension composition the process parameters and the technological configuration on milling performances and physical quality of the suspensions produced. The data suggested that both HPH and SBM are suitable for producing nano‐crystalline suspensions, although SBM appeared more efficient than HPH, since the limit of milling (d50) for SBM was found to be lower than that obtained with HPH (100 nm vs 200 nm). For both these technologies, regardless of the process parameters used for milling and the scale of manufacturing, the relationship of d90 versus d50 could be described by a unique master curve (technology signature of milling pathway) outlining that the HPH leads to more uniform particle size distribution as compared to SBM.


Journal of Pharmaceutical Sciences | 2017

New Approach and Practical Modelling of Bead Milling Process for the Manufacturing of Nanocrystalline Suspensions

Mostafa Nakach; Jean-Rene Authelin; Christophe Agut

Stirred media milling is the main technology for producing colloidal nanocrystalline suspensions. A number of studies have been reported on the effect of different operating parameters for lab, pilot, and industrial scales. However, typical milling tool box that can be used to support candidate from selection up to phase III clinical supplies can involve different mill configurations. This article describes a parametric study and milling kinetic modelling of the different mills. The impact of active pharmaceutical ingredient (API) type and process parameters on milling kinetics was determined. The milling kinetics were modeled using an empirical model which allows for predicting and simulation of milling kinetics of stirred annular and pin mills. The proposed model was found to accurately fit milling kinetics whatever the API considered, technology employed, and the process parameters used for milling. Moreover, the model was found to be able to ensure the process transfer from one mill to another.


International Journal of Mineral Processing | 2004

Comparison of various milling technologies for grinding pharmaceutical powders

Mostafa Nakach; Jean-Rene Authelin; Alain Chamayou; John Dodds


Archive | 2014

Formulation of aprepitant with enhanced solubility

Amandine Mathieu; Stéphanie Greco; Mostafa Nakach; Lionel Bardet; Jean Rene Authelin; Cyrus Victor Skaria; Josef Beranek; Ondrej Dammer; Lukas Krejcik; Pavla Chalupova; Aleksandra Dumicic


Archive | 2009

DIRECT DISSOLUTION OF DOCETAXEL IN A SOLVENT IN POLYSORBATE 80

Eric Didier; Elie Fouque; Mostafa Nakach; Jean-Rene Authelin


Drug Delivery Letters | 2018

Nano-crystalline suspensions by top down processes: Review of manufacturing considerations

Mostafa Nakach; Ranjita Shegokar; Jean-Rene Authelin; Tharwat Tadros


Archive | 2016

Scale-Up and cGMP Manufacturing of Nanodrug Delivery Systems for Clinical Investigations

Mostafa Nakach; Jean-Rene Authelin


Archive | 2008

Dissolution directe du docetaxel dans un solvant dans le poly sorbate 80

Jean-Rene Authelin; Eric Didier; Elie Fouque; Mostafa Nakach

Collaboration


Dive into the Mostafa Nakach's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge